parasitic%20infections
PARASITIC INFECTIONS
Gastrointestinal parasitic infection symptoms include abdominal pain, diarrhea, dysentery, flatulence, malabsorption and symptoms of biliary obstruction.
It can be caused by protozoan parasites and helminths.
Host susceptibility factors in gastrointestinal parasitic infections are nutritional status, intercurrent disease, pregnancy, immunosuppressive drugs and presence of a malignancy.
Knowledge of the geographic distribution of parasites is helpful in the diagnosis of patients.

Introduction

  • Parasites presents a continual & unacceptable threat to the well-being of millions of people in the tropics, subtropics, as well w/ domesticated animals
  • As more parasites are identified & implicated as a cause of disease, its life cycle elucidated, its control or eradication would follow w/ the development of drugs, vaccines & antivector measures

Signs and Symptoms

Gastrointestinal (GI)

  • Abdominal pain, diarrhea, dysentery, flatulence, malabsorption, symptoms of biliary obstruction

Nonspecific

  • Fever, malaise, fatigue, anorexia, sweating, weight loss, edema & pruritus
  • Some patients may be asymptomatic

Risk Factors

Host Susceptibility Factors in Gastrointestinal (GI) Parasitic Infections

  • Nutritional status
  • Intercurrent disease
  • Pregnancy
  • Immunosuppressive drugs
  • Presence of a malignancy
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
01 May 2014

New drug applications approved by US FDA as of 15-30 May which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

28 Apr 2017
Silymarin does not appear to be significantly better than placebo in reducing disease activity by 30 percent or more in patients with nonalcoholic steatohepatitis (NASH), according to the results of a trial.
08 May 2017
Transabdominal bowel wall ultrasonography shows utility in monitoring disease activity in patients with active Crohn’s disease (CD), according to a study. The imaging technique is ideal for evaluating early transmural changes in disease activity, in response to medical treatment.